BIOMARKERS OF TARGET THERAPIES IN LUNG CANCER

被引：0
|
作者：
Timar, J. [1 ]
Fillinger, J. [2 ]
Moldvay, J. [3 ]
机构：
[1] Semmelweis Univ, Dept Pathol 2, H-1085 Budapest, Hungary
[2] Natl Koranyi Inst Pulmonol, Budapest, Hungary
[3] Semmelweis Univ, Dept Pulmonol, H-1085 Budapest, Hungary
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2011年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：3 / 3
页数：1
相关论文
共 50 条
  • [31] The place of targeted therapies in the management of non-small cell bronchial carcinoma - Target therapies in lung cancer management
    Scagliotti, G. V.
    Selvaggi, G.
    REVUE DES MALADIES RESPIRATOIRES, 2006, 23 (05) : S137 - S147
  • [32] MYC in Oncogenesis and as a Target for Cancer Therapies
    Albihn, Ami
    Johnsen, John Inge
    Henriksson, Marie Arsenian
    ADVANCES IN CANCER RESEARCH, VOL 107, 2010, 107 : 163 - 224
  • [33] Nuclear transport as a target for cancer therapies
    Henderson, B
    DRUG DISCOVERY TODAY, 2003, 8 (06) : 249 - 249
  • [34] Finding biomarkers of resistance to targeted cancer therapies
    Bernards, Rene
    EJC SUPPLEMENTS, 2007, 5 (05): : 109 - 114
  • [35] Biomarkers, Molecular Imaging, and Novel Therapies of Cancer
    Li, Min
    CURRENT MOLECULAR MEDICINE, 2013, 13 (03) : 331 - 332
  • [36] Biomarkers in imaging for evaluation of new cancer therapies
    Cuenod, C. A.
    Fournier, L.
    Balvay, D.
    Thiam, R.
    Oudard, S.
    ONCOLOGIE, 2010, 12 (03) : 178 - 186
  • [37] Proteomic biomarkers in lung cancer
    M. D. Pastor
    A. Nogal
    S. Molina-Pinelo
    A. Carnero
    L. Paz-Ares
    Clinical and Translational Oncology, 2013, 15 : 671 - 682
  • [38] Salivary Biomarkers in Lung Cancer
    Skallevold, Hans E.
    Vallenari, Evan M.
    Sapkota, Dipak
    MEDIATORS OF INFLAMMATION, 2021, 2021
  • [39] Microbiota Biomarkers for Lung Cancer
    Leng, Qixin
    Holden, Van K.
    Deepak, Janaki
    Todd, Nevins W.
    Jiang, Feng
    DIAGNOSTICS, 2021, 11 (03)
  • [40] Proteomic biomarkers in lung cancer
    Pastor, M. D.
    Nogal, A.
    Molina-Pinelo, S.
    Carnero, A.
    Paz-Ares, L.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2013, 15 (09): : 671 - 682
12345